« FDA Unveils Initiative to Reduce Unnecessary Radiation Exposure from Medical | Main | FDA Announces Class I Recall of Certain Infusion Set Needles »

FDA Expands Use of Approved Breast Cancer Drug The U.S.


FDA Expands Use of Approved Breast Cancer Drug
The U.S. Food and Drug Administration today approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer in postmenopausal women for whom hormonal therapy is indicated.
 

©2006 FDA-News.com. All rights reserved.